TMEM69 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.000820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.426420E-01
Normal-vs-Stage2
1.258170E-01
Normal-vs-Stage3
2.226300E-02
Normal-vs-Stage4
4.023800E-01
Stage1-vs-Stage2
7.833600E-01
Stage1-vs-Stage3
1.064820E-01
Stage1-vs-Stage4
6.589400E-01
Stage2-vs-Stage3
1.642210E-01
Stage2-vs-Stage4
4.954600E-01
Stage3-vs-Stage4
1.128960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.936200E-02
Normal-vs-AfricanAmerican
2.115200E-01
Normal-vs-Asian
4.525400E-01
Caucasian-vs-AfricanAmerican
9.404200E-01
Caucasian-vs-Asian
2.885400E-01
AfricanAmerican-vs-Asian
5.868200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.630200E-02
Normal-vs-Female
2.543600E-01
Male-vs-Female
1.032400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.352000E-02
Normal-vs-Age(41-60Yrs)
1.088000E-01
Normal-vs-Age(61-80Yrs)
8.097700E-02
Normal-vs-Age(81-100Yrs)
3.388600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.015790E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.284200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.949200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.162400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.601800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.285800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.207430E-01
Normal-vs-Daily Drinker
8.256100E-02
Normal-vs-Weekly Drinker
8.978300E-02
Normal-vs-Occasional Drinker
9.471500E-02
Normal-vs-Social Drinker
6.339600E-02
Non Drinker-vs-Daily Drinker
7.514800E-01
Non Drinker-vs-Weekly Drinker
9.854800E-01
Non Drinker-vs-Occasional Drinker
8.690400E-02
Non Drinker-vs-Social Drinker
1.135420E-01
Daily Drinker-vs-Weekly Drinker
7.846200E-01
Daily Drinker-vs-Occasional Drinker
1.668830E-01
Daily Drinker-vs-Social Drinker
1.936220E-01
Weekly Drinker-vs-Occasional Drinker
1.538750E-01
Weekly Drinker-vs-Social Drinker
1.879970E-01
Occasional Drinker-vs-Social Drinker
8.597800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.820800E-01
Normal-vs-Grade 2
8.788600E-01
Normal-vs-Grade 3
8.978400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.509820E-02
Grade 1-vs-Grade 3
7.193900E-02
Grade 1-vs-Grade 4
9.820800E-01
Grade 2-vs-Grade 3
6.820000E-01
Grade 2-vs-Grade 4
8.788600E-01
Grade 3-vs-Grade 4
8.978400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.971700E-02
Normal-vs-NonDiabetic
7.634400E-02
Diabetic-vs-NonDiabetic
4.800800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.838200E-02
Normal-vs-NoPancreatitis
8.857800E-02
Pancreatitis-vs-NoPancreatitis
9.319000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.153630E-01
Normal-vs-N1
1.047840E-01
N0-vs-N1
8.031200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.872800E-01
Normal-vs-TP53-NonMutant
1.942760E-01
TP53-Mutant-vs-TP53-NonMutant
4.418000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
